The digital transformation of pathology is opening up new possibilities for cancer diagnosis. Today's artificial intelligence ...
Like all forms of cancer, lung cancer is defined by uncontrolled cell division caused by loss of physiological tissue homeostasis and failure of apoptotic cell death mechanisms. Aberrant cell ...
Digital pathology and artificial intelligence are transforming the drug development landscape, accelerating the path to ...
The digital transformation of pathology is opening up new possibilities for cancer diagnosis. Today’s artificial intelligence (AI) techniques now go far beyond mere automation: they make it possible ...
PathAI makes AI models that help with the analysis of patient tissue samples and diagnostic tools. Roche has partnered with ...
Artificial intelligence is beginning to reshape how cancer treatment decisions are made. In a significant development, the ...
QIMR Berghofer researchers developed STimage, an AI-powered pathology tool that detects hidden cancer biomarkers in standard ...
At ESMO Congress 2024, Shuji Ogino, MD, PhD, MS, explained that the rising incidence of young-onset cancer may be due to generational risk factors such as lifestyle, diet, and environmental changes, ...
QIMR Berghofer scientists have developed an AI screening tool that harnesses the power of cutting-edge spatial biology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results